Elazar Rabbani Ph.D.
Net Worth
Last updated:
What is Elazar Rabbani Ph.D. net worth?
The estimated net worth of Dr. Elazar Rabbani Ph.D. is at least $18,404,990 as of 14 Jan 2019. He owns shares worth $580,112 as insider, has earned $843,858 from insider trading and has received compensation worth at least $16,981,020 in Enzo Biochem, Inc..
What is the salary of Elazar Rabbani Ph.D.?
Dr. Elazar Rabbani Ph.D. salary is $808,620 per year as Co-Founder, Chairman, Chief Scientific Officer & Sec. in Enzo Biochem, Inc..
How old is Elazar Rabbani Ph.D.?
Dr. Elazar Rabbani Ph.D. is 82 years old, born in 1943.
What stocks does Elazar Rabbani Ph.D. currently own?
As insider, Dr. Elazar Rabbani Ph.D. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Enzo Biochem, Inc. (ENZ) | Co-Founder, Chairman, Chief Scientific Officer & Sec. | 1,848,668 | $0.31 | $580,112 |
What does Enzo Biochem, Inc. do?
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical research, drug development, and bioscience research customers. It offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also provides its products to scientific experts in the fields of cancer, cardiovascular disease, neurological disorders, diabetes and obesity, endocrine disorders, infectious and autoimmune disease, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment provides molecular and other clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It operates a full-service clinical laboratory in Farmingdale, New York; a network of 30 patient service centers in New York and New Jersey; and a free-standing 'STAT' or rapid response laboratories in New York City and Connecticut, as well as a full-service phlebotomy center and an in-house logistics department. The Therapeutics segment develops novel approaches in the areas of gastrointestinal, infectious, ophthalmic, and metabolic diseases. It markets its products and services through its direct sales force and a network of distributors in the United States and internationally. The company was founded in 1976 and is headquartered in New York, New York.
Elazar Rabbani Ph.D. insider trading
Enzo Biochem, Inc.
Dr. Elazar Rabbani Ph.D. has made 3 insider trades between 2004-2019, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 568,276 units of ENZ stock on 26 Apr 2004. As of 14 Jan 2019 he still owns at least 1,848,668 units of ENZ stock.
Enzo Biochem key executives
Enzo Biochem, Inc. executives and other stock owners filed with the SEC:
- Dr. Dieter Schapfel M.D. (62) Chief Medical Director of Enzo Clinical Labs
- Dr. Elazar Rabbani Ph.D. (82) Co-Founder, Chairman, Chief Scientific Officer & Sec.
- Mr. Barry W. Weiner (75) Founder, Treasurer & Pres